AAAAAA

   
Results: 1-8 |
Results: 8
Collocation of androgen receptor gene mutations in prostate cancer
Authors: Buchanan, G Greenberg, NM Scher, HI Harris, JM Marshall, VR Tilley, WD
Citation: G. Buchanan et al., Collocation of androgen receptor gene mutations in prostate cancer, CLIN CANC R, 7(5), 2001, pp. 1273-1281
Mutations at the boundary of the hinge and ligand binding domain of the androgen receptor confer increased transactivation function
Authors: Buchanan, G Yang, MO Harris, JM Nahm, HS Han, GZ Moore, N Bentel, JM Matusik, RJ Horsfall, DJ Marshall, VR Greenberg, NM Tilley, WD
Citation: G. Buchanan et al., Mutations at the boundary of the hinge and ligand binding domain of the androgen receptor confer increased transactivation function, MOL ENDOCR, 15(1), 2001, pp. 46-56
Hormone status selects for spontaneous somatic androgen receptor variants that demonstrate specific ligand and cofactor dependent activities in autochthonous prostate cancer
Authors: Han, GZ Foster, BA Mistry, S Buchanan, G Harris, JM Tilley, WD Greenberg, NM
Citation: Gz. Han et al., Hormone status selects for spontaneous somatic androgen receptor variants that demonstrate specific ligand and cofactor dependent activities in autochthonous prostate cancer, J BIOL CHEM, 276(14), 2001, pp. 11204-11213
Versican accumulation in human prostatic fibroblast cultures is enhanced by prostate cancer cell-derived transforming growth factor beta 1
Authors: Sakko, AJ Ricciardelli, C Mayne, K Tilley, WD LeBaron, RG Harosfall, DJ
Citation: Aj. Sakko et al., Versican accumulation in human prostatic fibroblast cultures is enhanced by prostate cancer cell-derived transforming growth factor beta 1, CANCER RES, 61(3), 2001, pp. 926-930
Breast cancer susceptibility gene 1 (BRCA1) is a coactivator of the androgen receptor
Authors: Park, JJ Irvine, RA Buchanan, G Koh, SS Park, JM Tilley, WD Stallcup, MR Press, MF Coetzee, GA
Citation: Jj. Park et al., Breast cancer susceptibility gene 1 (BRCA1) is a coactivator of the androgen receptor, CANCER RES, 60(21), 2000, pp. 5946-5949
Androgen receptor expression in primary prostate cancers of Lobund-Wistar rats and in tumor-derived cell lines
Authors: Bentel, JM Pickering, MA Pollard, M Clements, JA Tilley, WD
Citation: Jm. Bentel et al., Androgen receptor expression in primary prostate cancers of Lobund-Wistar rats and in tumor-derived cell lines, IN VITRO-AN, 35(10), 1999, pp. 655-662
Androgen receptor agonist activity of the synthetic progestin, medroxyprogesterone acetate, in human breast cancer cells
Authors: Bentel, JM Birrell, SN Pickering, MA Holds, DJ Horsfall, DJ Tilley, WD
Citation: Jm. Bentel et al., Androgen receptor agonist activity of the synthetic progestin, medroxyprogesterone acetate, in human breast cancer cells, MOL C ENDOC, 154(1-2), 1999, pp. 11-20
Elevated levels of peritumoral chondroitin sulfate are predictive of poor prognosis in patients treated by radical prostatectomy for early-stage prostate cancer
Authors: Ricciardelli, C Quinn, DI Raymond, WA McCaul, K Sutherland, PD Stricker, PD Grygiel, JJ Sutherland, RL Marshall, VR Tilley, WD Horsfall, DJ
Citation: C. Ricciardelli et al., Elevated levels of peritumoral chondroitin sulfate are predictive of poor prognosis in patients treated by radical prostatectomy for early-stage prostate cancer, CANCER RES, 59(10), 1999, pp. 2324-2328
Risultati: 1-8 |